Skip to main content
Premium Trial:

Request an Annual Quote

Sequenom Files Infringement Suit Against Ibis

NEW YORK (GenomeWeb News) – Sequenom President and CEO Harry Stylli said during the firm’s third-quarter conference call last night that the firm had filed a patent infringement suit against Ibis Biosciences for allegedly infringing three Sequenom patents related to nucleic acid analysis by mass spectrometry.
He offered few details about the suit, which was filed against the subsidiary of Carlsbad, Calif.-based Isis Pharmaceuticals yesterday in the US District Court in the District of Delaware. The filing does not yet appear on the court’s website.
Stylli alleged that Ibis’ T5000 Biosensor System and related technology infringes the Sequenom patents. He said the firm is seeking a permanent injunction that would bar the sale of the biosensor and related technologies as well as monetary damages.
Responding to a question during the call regarding legal expenses associated with the action against Ibis, Stylli said that those expected costs have already been built into the firm’s expectations for SG&A expenses. He declined to comment further on the cost, other than saying, “it’s not expected to be that much in the next 12 months. Frankly, we’re hoping that we’ll work out some kind of business solution.”
While Ibis is currently owned by Isis Pharmaceuticals, Abbott holds a nearly 20 percent stake in the subsidiary with an option to buy the remainder of Ibis through June 2009.

The Scan

Not as High as Hoped

The Associated Press says initial results from a trial of CureVac's SARS-CoV-2 vaccine suggests low effectiveness in preventing COVID-19.

Finding Freshwater DNA

A new research project plans to use eDNA sampling to analyze freshwater rivers across the world, the Guardian reports.

Rise in Payments

Kaiser Health News investigates the rise of payments made by medical device companies to surgeons that could be in violation of anti-kickback laws.

Nature Papers Present Ginkgo Biloba Genome Assembly, Collection of Polygenic Indexes, More

In Nature this week: a nearly complete Ginkgo biloba genome assembly, polygenic indexes for dozens of phenotypes, and more.